Basal Cell Carcinoma Press Releases

Published: Tietze JK, et al. Clin Nucl Med. 2023;48(10):869–876.

OncoBeta® GmbH, a medical device company specialised in innovative epidermal radioisotope therapies, has confirmed the phase IV international multi-centre study designed to further evaluate the Complete Response Rate of patients with non-melanoma skin...

Non-invasive therapy for non-melanoma skin cancer is now available at select GenesisCare treatment sites